Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 4/2016

01-04-2016 | Gastrointestinal Oncology

Is All Advanced Gastric Cancer Suitable for Laparoscopy-Assisted Gastrectomy With Extended Lymphadenectomy? A Case–Control Study Using a Propensity Score Method

Authors: Jian-Xian Lin, MM, Chang-Ming Huang, MD, Chao-Hui Zheng, MD, Ping Li, MD, Jian-Wei Xie, MD, Jia-bin Wang, MD, Lu Jun, MM, Qi-Yue Chen, MM, Long-long Cao, MM, Mi Lin, MM

Published in: Annals of Surgical Oncology | Issue 4/2016

Login to get access

Abstract

Background

The oncologic outcomes of laparoscopy-assisted gastrectomy (LAG) for the treatment of patients with local advanced gastric cancer (AGC) have not been evaluated. This study aimed to validate the oncologic efficacy of LAG for AGC.

Methods

The data from 539 patients who underwent LAG and 539 patients treated with open gastrectomy (OG) were selected using the propensity score-matching method from a database prospectively constructed between 2005 and 2011. The therapeutic value of lymph node (LN) dissection and the long-term surgical outcomes of these matched groups were compared.

Results

The groups were well balanced after the propensity score matched. The LAG and OG groups did not differ significantly in terms of clinicopathologic characteristics. The number of dissected LNs at stations 11 and 12a were significantly higher in the LAG group. However, the therapeutic index at each LN station did not differ significantly between the two groups. Although the overall survival curve at each stage did not differ significantly (P > 0.05), the survival rate increased overall for patients with pT4aN3bM0 in the OG group (P < 0.05). The stratified analysis showed that overall survival was inferior for LAG surgeons with fewer than 40 completed cases. The survival results for surgeons who had performed more than 40 cases were similar to the results from open surgery.

Conclusions

Although LAG yields comparable oncologic outcomes for local AGC, patients with pT4aN3bM0 gastric cancer may not be suitable for laparoscopic surgery, especially for surgeons with limited experience.
Literature
1.
Hur H, Jeon HM, Kim W. Laparoscopy-assisted distal gastrectomy with D2 lymphadenectomy for T2b advanced gastric cancers: three years’ experience. J Surg Oncol. 2008;98:515–9.CrossRefPubMed
2.
Kawamura H, Homma S, Yokota R, Yokota K, Watarai H, Hagiwara M, Sato M, Noguchi K, Ueki S, Kondo Y. Inspection of safety and accuracy of D2 lymph node dissection in laparoscopy- assisted distal gastrectomy. World J Surg. 2008;32:2366–70.CrossRefPubMed
3.
Tanimura S, Higashino M, Fukunaga Y, Takemura M, Tanaka Y, Fujiwara Y, Osugi H. Laparoscopic gastrectomy for gastric cancer: experience with more than 600 cases. Surg Endosc. 2008;22:1161–4.CrossRefPubMed
4.
Kim KH, Kim MC, Jung GJ, Kim HH. Long-term outcomes and feasibility with laparoscopy-assisted gastrectomy for gastric cancer. J Gastric Cancer. 2012;12:18–25.CrossRefPubMedPubMedCentral
5.
Hu YF, Yu J, Zhang C, Wang YN, Cheng X, Huang F, Li GX. Development and implementation of a clinical data mining system for gastric cancer surgery (in Chinese). Chin J Gastrointest Surg. 2010;13:510–5.
6.
Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma. 2nd English Edition. Gastric Cancer. 1998;1:10–24.CrossRef
7.
Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 3rd English edition. Gastric Cancer. 2011;14:101–12.CrossRef
8.
Huang CM, Chen QY, Lin JX, Zheng CH, Li P, Xie JW. Huang’s three-step maneuver for laparoscopic spleen-preserving no. 10 lymph node dissection for advanced proximal gastric cancer. Chin J Cancer Res. 2014;26:208–10.
9.
Sobin LH, Gospodarowicz MK, Wittekind C. International Union Against Cancer (UICC) TNM classification of malignant tumours. 7th ed. New York: Wiley; 2010.
10.
D’Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a nonrandomized control group. Stat Med. 1998;17:2265–81.CrossRefPubMed
11.
Sasako M, McCulloch P, Kinoshita T, Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995;82:346–51.CrossRefPubMed
12.
Aiko T, Sasako M. The new Japanese classification of gastric carcinoma: points to be revised. Gastric Cancer. 1998;1:25–30.CrossRefPubMed
13.
Kosuga T, Ichikawa D, Okamoto K, Komatsu S, Shiozaki A, Fujiwara H, Otsuji E. Survival benefits from splenic hilar lymph node dissection by splenectomy in gastric cancer patients: relative comparison of the benefits in subgroups of patients. Gastric Cancer. 2011;14:172–7.CrossRefPubMed
14.
Tokunaga M, Ohyama S, Hiki N, Fukunaga T, Inoue H, Yamada K, Sano T, Yamaguchi T, Nakajima T. Therapeutic value of lymph node dissection in advanced gastric cancer with macroscopic duodenum invasion: is the posterior pancreatic head lymph node dissection beneficial? Ann Surg Oncol. 2009;16:1241–6.CrossRefPubMed
15.
Kim HH, Han SU, Kim MC, Hyung WJ, Kim W, Lee HJ, Ryu SW, Cho GS, Song KY, Ryu SY. Long-term results of laparoscopic gastrectomy for gastric cancer: a large-scale case-control and case-matched Korean multicenter study. J Clin Oncol. 2014;32:627–33.CrossRefPubMed
16.
Kitano S, Iso Y, Moriyama M, Sugimachi K. Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc. 1994;4:146–8.PubMed
17.
Ohtani H, Tamamori Y, Noguchi K, Azuma T, Fujimoto S, Oba H, Aoki T, Minami M, Hirakawa K. A meta-analysis of randomized controlled trials that compared laparoscopy-assisted and open distal gastrectomy for early gastric cancer. J Gastrointest Surg. 2010;14:958–64.CrossRefPubMed
18.
Ohtani H, Tamamori Y, Noguchi K, Azuma T, Fujimoto S, Oba H, Aoki T, Minami M, Hirakawa K. Meta-analysis of laparoscopy-assisted and open distal gastrectomy for gastric cancer. J Surg Res. 2011;171:479–85.CrossRefPubMed
19.
Kim HH, Hyung WJ, Cho GS, Kim MC, Han SU, Kim W, Ryu SW, Lee HJ, Song KY. Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report: a phase III multicenter, prospective, randomized trial (KLASS Trial). Ann Surg. 2010;251:417–20.CrossRefPubMed
20.
Lin JX, Huang CM, Zheng CH, Li P, Xie JW, Wang JB, Lu J. Laparoscopy-assisted gastrectomy with D2 lymph node dissection for advanced gastric cancer without serosa invasion: a matched cohort study from South China. World J Surg Oncol. 2013;11:4.CrossRefPubMedPubMedCentral
21.
Nam BH, Kim YW, Reim D, Eom BW, Yu WS, Park YK, Ryu KW, Lee YJ, Yoon HM, Lee JH, Jeong O, Jeong SH, Lee SE, Lee SH, Yoon KY, Seo KW, Chung HY, Kwon OK, Kim TB, Lee WK, Park SH, Sul JY, Yang DH, Lee JS. Laparoscopy-assisted versus open distal gastrectomy with D2 lymph node dissection for advanced gastric cancer: design and rationale of a phase II randomized controlled multicenter trial (COACT 1001). J Gastric Cancer. 2013;13:164–71.CrossRefPubMedPubMedCentral
22.
Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol. 2005;23:7114–24.CrossRefPubMed
23.
Pak KH, Hyung WJ, Son T, Obama K, Woo Y, Kim HI, An JY, Kim JW, Cheong JH, Choi SH, Noh SH. Long-term oncologic outcomes of 714 consecutive laparoscopic gastrectomies for gastric cancer: results from the 7-year experience of a single institute. Surg Endosc. 2012;26:130–6.CrossRefPubMed
24.
Strong VE, Devaud N, Allen PJ, Gonen M, Brennan MF, Coit D. Laparoscopic versus open subtotal gastrectomy for adenocarcinoma: a case-control study. Ann Surg Oncol. 2009;16:1507–13.CrossRefPubMed
25.
Zhao XF, Jeong O, Jung MR, Ryu SY, Park YK. A propensity score-matched case-control comparative study of laparoscopic and open extended (D2) lymph node dissection for distal gastric carcinoma. Surg Endosc. 2013;27:2792–800.CrossRefPubMed
26.
Huang CM, Chen QY, Lin JX, Zheng CH, Li P, Xie JW, Wang JB, Lu J, Yang XT. Laparoscopic suprapancreatic lymph node dissection for advanced gastric cancer using a left-sided approach. Ann Surg Oncol. 2015;22:2351.CrossRefPubMed
27.
Bo T, Peiwu Y, Feng Q, Yongliang Z, Yan S, Yingxue H, Huaxing L. Laparoscopy-assisted vs open total gastrectomy for advanced gastric cancer: long-term outcomes and technical aspects of a case-control study. J Gastrointest Surg. 2013;17:1202–8.CrossRefPubMed
28.
Park do J, Han SU, Hyung WJ, Kim MC, Kim W, Ryu SY, Ryu SW, Song KY, Lee HJ, Cho GS, Kim HH. Long-term outcomes after laparoscopy-assisted gastrectomy for advanced gastric cancer: a large-scale multicenter retrospective study. Surg Endosc. 2012;26:1548–53.
29.
Shuang J, Qi S, Zheng J, Zhao Q, Li J, Kang Z, Hua J, Du J. A case-control study of laparoscopy-assisted and open distal gastrectomy for advanced gastric cancer. J Gastrointest Surg. 2011;15:57–62.CrossRefPubMed
30.
Lee YJ, Ha WS, Park ST, Choi SK, Hong SC. Port-site recurrence after laparoscopy-assisted gastrectomy: report of the first case. J Laparoendosc Adv Surg Tech A. 2007;17:455–7.CrossRefPubMed
Metadata
Title
Is All Advanced Gastric Cancer Suitable for Laparoscopy-Assisted Gastrectomy With Extended Lymphadenectomy? A Case–Control Study Using a Propensity Score Method
Authors
Jian-Xian Lin, MM
Chang-Ming Huang, MD
Chao-Hui Zheng, MD
Ping Li, MD
Jian-Wei Xie, MD
Jia-bin Wang, MD
Lu Jun, MM
Qi-Yue Chen, MM
Long-long Cao, MM
Mi Lin, MM
Publication date
01-04-2016
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 4/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-4994-1

Other articles of this Issue 4/2016

Annals of Surgical Oncology 4/2016 Go to the issue

Hepatobiliary Tumors

Is Tumor Detachment from Vascular Structures Equivalent to R0 Resection in Surgery for Colorectal Liver Metastases? An Observational Cohort

Melanomas

Australian Multicenter Study of Isolated Limb Infusion for Melanoma

Colorectal Cancer

Transanal Endoscopic Microsurgery (TEM) Following Neoadjuvant Chemoradiation for Rectal Cancer: Outcomes of Salvage Resection for Local Recurrence

Gynecologic Oncology

Preoperative Prediction of Cardiophrenic Lymph Node Metastasis in Advanced Ovarian Cancer Using Computed Tomography

Gynecologic Oncology

Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network

Hepatobiliary Tumors

Should ALPPS be Used for Liver Resection in Intermediate-Stage HCC?